While it is known that IL-10 is one of the cytokines activating STAT3—a well-known activator of transcription that plays an important role of renal cell carcinoma development—increased STAT3 activation correlates with both advanced metastatic disease and worse survival in RCC [23]. The gene discussed is IL10; the disease is renal cell carcinoma.